Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥3 cm

HPB

Volumn 17, Issue 2, 2015, Pages 140-149

  Jacob, Rojymon ^a   Turley, Falynn ^b   Redden, David T ^b   Saddekni, Souheil ^c   Aal, Ahmed K A ^c   Keene, Kimberly ^a   Yang, Eddy ^a   Zarzour, Jessica ^c   Bolus, David ^c   Smith, J Kevin ^c   Gray, Stephen ^b   White, Jared ^b   Eckhoff, Devin E ^b   Dubay, Derek A ^b  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SORAFENIB;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; TUMOR VOLUME; ADJUVANT THERAPY; AGED; CARCINOMA, HEPATOCELLULAR; COMPUTER ASSISTED TOMOGRAPHY; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; RADIOGRAPHY; RADIOSURGERY;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84920723070     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12331     Document Type: Article

References (35)

1. Bruix J, Sherman M,. (2011) American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022.
2. Bruix J, Sherman M, Practice Guidelines Committee American Association for the Study of Liver Diseases. (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236.
3. Forner A, Reig ME, de Lope CR, Bruix J,. (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30: 61-74.
4. Llovet JM, Bru C, Bruix J,. (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19: 329-338.
5. National Comprehensive Cancer Network. (2013) National Comprehensive cancer Network guidelines for hepatobiliary cancers. Available at http://www.nccn.org/professionals/physician-gls/f-guidelines.asp (last accessed 4 January 2014).
6. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35: 1164-1171.
7. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359: 1734-1739.
8. Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, et al. (2006) Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev 32: 594-606.
9. Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, et al. (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26: 657-664.
10. Choi BO, Jang HS, Kang KM, Lee SW, Kang YN, Chai GY, et al. (2006) Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn J Clin Oncol 36: 154-158.
11. Bujold A, Massey CA, Kim JJ, Brierley J, Cho C, Wong RK, et al. (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31: 1631-1639.
12. Kang JK, Kim MS, Cho CK, Yang KM, Yoo HJ, Kim JH, et al. (2012) Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization. Cancer 118: 5424-5431.
13. Huang WY, Jen YM, Lee MS, Chang LP, Chen CM, Ko KH, et al. (2012) Stereotactic body radiation therapy in recurrent hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 84: 355-361.
14. O'Connor JK, Trotter J, Davis GL, Dempster J, Klintmalm GB, Goldstein RM,. (2012) Longterm outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. Liver Transplant 18: 949-954.
15. Piro AJ, Taylor CC, Belli JA,. (1975) Interaction between radiation and drug damage in mammalian cells. I. Delayed expression of actinomycin D/x-ray effects in exponential and plateau phase cells. Radiat Res 63: 346-362.
16. Dorn DP, Bryant MK, Zarzour J, Smith JK, Redden DT, Saddekni S, et al. (2013) Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function. HPB 16: 648-655.
17. Bryant MK, Dorn DP, Zarzour J, Smith JK, Redden DT, Saddekni S, et al. (2013) Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization. HPB 16: 327-335.
18. Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, et al. (2006) Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45: 848-855.
19. Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J,. (2013) New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 266: 376-382.
20. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 421-430.
21. Lencioni R, Llovet JM,. (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30: 52-60.
22. Englesbe MJ, Terjimanian MN, Lee JS, Sheetz KH, Harbaugh CM, Hussain A, et al. (2013) Morphometric age and surgical risk. J Am Coll Surg 216: 976-985.
23. Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T,. (2002) Cirrhosis: modified caudate-right lobe ratio. Radiology 224: 769-774.
24. Lee JK, Sagel SR, Stanley RJ,. (2003) Computed Body Tomography with MRI Correlation, 4th edn. Philadelphia, PA: Lippincott, Williams & Wilkins, pp. 894-897.
25. Ito K, Mitchell DG, Siegelman ES,. (2002) Cirrhosis: MR imaging features. Magn Reson Imaging Clin N Am 10: 75-92, vi.
26. Bolondi L, Burroughs A, Dufour JF, Galle PR, Mazzaferro V, Piscaglia F, et al. (2012) Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis 32: 348-359.
27. Kadalayil L, Benini R, Pallan L, O'Beirne J, Marelli L, Yu D, et al. (2013) A simple prognostic scoring system for patients receiving transarterial embolization for hepatocellular cancer. Ann Oncol 24: 2565-2570.
28. Sieghart W, Hucke F, Pinter M, Graziadei I, Vogel W, Muller C, et al. (2013) The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma. Hepatology 57: 2261-2273.
29. Solberg TD, Balter JM, Benedict SH, Fraass BA, Kavanagh B, Miyamoto C, et al. (2012) Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: executive summary. Pract Radiat Oncol 2: 2-9.
30. Liao M, Huang J, Zhang T, Wu H,. (2013) Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: a meta-analysis. PLoS ONE 8: e68453.
31. Meng MB, Cui YL, Lu Y, She B, Chen Y, Guan YS, et al. (2009) Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Radiother Oncol 92: 184-194.
32. Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, et al. (2011) Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 81: e447-e453.
33. Yang JC, Wexler LH, Meyers PA, Happersett L, La Quaglia MP, Wolden SL,. (2013) Intensity-modulated radiation therapy with dose-painting for paediatric sarcomas with pulmonary metastases. Pediatr Blood Cancer 60: 1616-1620.
34. Azcona JD, Li R, Mok E, Hancock S, Xing L,. (2013) Development and clinical evaluation of automatic fiducial detection for tumour tracking in cine megavoltage images during volumetric modulated arc therapy. Med Phys 40: 031708.
35. Austin PC,. (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46: 399-424.